Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Rang in aandelen #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Aandeelprijs
$0.1559364
Laatst gesynchroniseerd: 2026-09-18
Marktkapitalisatie
$195.17K
Verandering (1 dag)
6.60%
Verandering (1 jaar)
-30.91%
Land
GB
Handel Fusion Antibodies plc (FAB)

Categorie

P/S-ratio voor Fusion Antibodies plc (FAB)
P/S-ratio op September 2026 TTM: 7.25
Volgens de meest recente financiële rapporten en aandelenkoers van Fusion Antibodies plc is de huidige P/S-ratio (TTM) 7.25. Eind 2024 had het bedrijf een P/S-ratio van 1.88.
P/S-ratiohistoriek voor Fusion Antibodies plc van 2013 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
2026 (TTM) 7.25 141.79%
2025 3.00 59.38%
2024 1.88 -45.47%
2023 3.45 6.43%
2022 3.24 -66.20%
2021 9.60 78.11%
2020 5.39 86.72%
2019 2.89 -54.34%
2018 6.32 -55.67%
2017 14.25 -22.61%
2016 18.42 -38.61%
2015 30.00 -20.48%
2014 37.73 -43.99%
2013 67.37 0.00%
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
10.44 43.99%
US
12.01 65.53%
NL
26.12 260.14%
US
3.76 -48.23%
AU
- -
CH